New Covid vaccine Nuvaxovid approved after almost 50,000 people involved in UK clinical trials

A fifth Covid vaccination has been given regulatory approval in the UK. Nuvaxovid, developed by Novavax, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) after safety, quality and effectiveness tests. The next step will see it considered for use in the Covid-19 vaccination programme, health secretary Sajid Javid said today (Thursday, February 3). It follows approval given for Moderna, Oxford/AstraZeneca, Pfizer/BioNTech and the Janssen vaccine (although this is not currently available), the NHS says. Almost 50,000 people were involved in clinical trails for the new vaccine. Mr Javid said: 'It is great to see our world renowned medicines regulator approve another COVID-19 vaccine.